Search for: "In Re B & W Management, Inc." Results 121 - 140 of 301
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 May 2011, 11:46 pm
Therasense, now Abbott, got into a patent battle involving 5,820,551 and similar patents claiming "disposable blood glucose test strips for diabetes management. [read post]
23 Nov 2008, 4:54 am
We continue to be of the view that some disclosures of non-GAAP financial measures could give rise to actions under Rule 10b-5.Section 3(b) of the Sarbanes-Oxley Act provides that a violation of that Act or the Commission's rules thereunder shall be treated for all purposes as a violation of the Exchange Act. [read post]
9 Apr 2009, 9:27 am
(IP finance)   Africa Outsourcing (IP management) to Africa? [read post]
31 Jan 2018, 7:52 am by Peter Breslauer
The Ninth Circuit reaffirmed that the burden of proving common legal questions predominate is, like all of the Rule 23(b)(3) requirements, on the plaintiff, and the relaxation of Rule 23(b)(3) for settlements that the Supreme Court recognized in Amchem Prods., Inc. v. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  In short, biotech cases remain manageable risks if they are defended correctly, especially if biotech management takes proactive steps to manage its disclosures in a way that will further   limit its risks. [read post]
2 Nov 2010, 1:40 am
Apotex did manage to invalidate "kit" claims of asserted 6,598,603 and 6,899,099. [read post]
8 Feb 2010, 4:02 am
Marathon Oil (Patently-O)   US Patents – Lawsuits and strategic steps B-K Lighting – B-K appeals from order declaring case exceptional under § 285 and awarding attorneys’ fees: B-K Lighting v. [read post]